Mizuno Corporation · Year ended March 2026

Direct sales in Japan helped Mizuno’s profit grow

Mizuno makes and sells sporting goods, including football shoes, golf clubs and baseball equipment. It also applies sports-product development knowledge to Sportstyle footwear and products for the workplace.

A salesperson presents an unbranded shoe to an adult customer across a shop counter

Make the shoe and sell directly to the wearer

The shoe and its route to the wearer

Mizuno links more direct selling of Sportstyle shoes in Japan with a higher gross margin.

A laced low-top shoe with a layered sole, shown as a generic physical product

Apply sports-product knowledge

Sportstyle shoes are one application described in the results.

An adult salesperson passes a shoe across a counter to an adult customer, beside shoe shelves and a shoe box

Mizuno sells to the consumer

The customer buys through the maker’s direct sales channel.

A schematic view of the product and direct-selling relationship.

Source: financial results, PDF p.4

Golf moved differently in the Americas and Korea

CONCEPT MAP

Different regional influences on profit

A summary of the company’s explanations for the year ended March 2026.

Selling Mizuno products
  1. Japan: the sales routeMore direct sales, centered on Sportstyle, improved gross margin
  2. Americas: supply costsTariffs pressured profit despite strong golf sales
  3. Asia: product mixHigher-margin golf lost sales amid a weak Korean market

Europe’s growth also includes a change in months consolidated

DATA VIEW

Japan’s role in regional operating profit

Regional operating profit for the year ended March 2026. Bars use ¥ million and labels ¥ billion, on one zero-based scale. Affected former European branches contribute twelve months this year versus nine in the prior year; only current-year amounts are plotted.

Japan’s role in regional operating profit
Japan¥15.218bn
Europe¥1.410bn
Americas¥2.423bn
Asia and Oceania¥3.565bn

Source: financial results, PDF p.18. The adjustment eliminating intersegment transactions is −¥14m. Amounts are truncated below ¥1m, so displayed figures do not reconcile exactly to consolidated operating profit.

THE VIEW AFTER THE NUMBERS

What the numbers suggest

Japan’s operating-profit increase exceeded Mizuno’s consolidated increase in the year ended March 2026. Within Japan, growth in direct selling to consumers, centered on Sportstyle shoes, supported an improvement in gross margin.

Tariff costs weighed on the Americas, while golf demand and product mix affected Asia and Oceania. Japan expanded direct selling while overseas businesses faced different cost and demand pressures. Selling products under the same brand leaves each region with different work to do to improve profit.

Share this article

Share on X

This is not investment advice or a stock recommendation. We reorder company-published primary-source facts to make the shape of the business easier to see.

Primary sources used

Consolidated financial results, year ended March 2026 (Japanese)

Mizuno Corporation · 2026-05-12

Pages used: p.4 / p.4,18 / p.4,9 / p.5

Open source →

NEXT COMPANY

Santen Pharmaceutical Co., Ltd. · Year ended March 2026

Look at the next company

Santen gains Chinese distribution rights for five eye drops

Santen develops and sells eye medicines and expands regional portfolios through partnerships for other companies’ products. In the year ended March 2026, Japanese drug-price reductions and generic competition weighed on consolidated revenue, which fell to ¥291.6bn. EMEA growth of 7.8% became 0.4% when currency effects were excluded. Understanding the Chinese distribution agreement and the next year’s growth forecast requires attention to the rights involved, regional pricing conditions, currency and selling costs.

See the company through the numbers →
5 productsAbbVie eye drops with mainland Chinese distribution rights: May 2026 presentation